Zobrazeno 1 - 10
of 102
pro vyhledávání: '"Stamatis-Nick C. Liossis"'
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
Systemic sclerosis (SSc) is a chronic, autoimmune, multisystem disease characterized by tissue fibrosis that, apart from the skin, may affect the lungs among other organs. B cells have been found in tissue lymphocytic infiltrates; in the lungs are en
Externí odkaz:
https://doaj.org/article/3d96b5a0319a49188b93de923d14c768
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
Autoimmune rheumatic diseases may affect vital organs with lung involvement being severe and difficult to treat manifestation. Systemic sclerosis (SSc) commonly affects the lung in the form of interstitial lung disease (ILD). ILD may be also seen in
Externí odkaz:
https://doaj.org/article/8f1e175581254ad198da2719e9697335
Publikováno v:
Rheumatology and Therapy, Vol 7, Iss 4, Pp 1045-1052 (2020)
Abstract Immune checkpoint inhibitors are a promising new therapeutic strategy in oncology that aims to eliminate cancer cells by enhancing patients' immune response against tumor antigens. Despite their beneficial effects, immune checkpoint inhibito
Externí odkaz:
https://doaj.org/article/7f01d5afd62842c684c7064acca17778
Autor:
S. Panopoulos, Κ. Chatzidionysiou, M. G. Tektonidou, V. K. Bournia, A. A. Drosos, Stamatis-Nick C. Liossis, T. Dimitroulas, L. Sakkas, D. Boumpas, P. V. Voulgari, D. Daoussis, K. Thomas, G. Georgiopoulos, G. Vosvotekas, Α. Garyfallos, P. Sidiropoulos, G. Bertsias, D. Vassilopoulos, P. P. Sfikakis
Publikováno v:
Arthritis Research & Therapy, Vol 22, Iss 1, Pp 1-8 (2020)
Abstract Background European data indicate that systemic sclerosis (SSc)-related death rates are increasing, thus raising concerns about SSc’s optimal management. Herein, we describe current treatment modalities and drug survival in a real-life SSc
Externí odkaz:
https://doaj.org/article/6097fdb60fdd445b9edc60e084268f7d
Publikováno v:
International Journal of Rheumatology, Vol 2011 (2011)
Systemic sclerosis (SSc) is a systemic rheumatic disease with poor prognosis since therapeutic options are limited. Recent evidence from animal models suggests that B-cells may be actively involved in the fibrotic process. B-cells from tight skin mic
Externí odkaz:
https://doaj.org/article/5ac760f9daf54e6a818a0dfec9ea0e28
Autor:
Maria G Tektonidou, Georgios Georgiopoulos, P.P. Sfikakis, Dimitrios T. Boumpas, Stamatis-Nick C. Liossis, V.-K. Bournia, Theodoros Dimitroulas, Lazaros I. Sakkas, Κ. Chatzidionysiou, Stylianos Panopoulos, Konstantinos Thomas, Alexandros A. Drosos, D. Daoussis, G. Vosvotekas, Dimitrios Vassilopoulos, Paraskevi V. Voulgari, Prodromos Sidiropoulos, Α. Garyfallos, G. Bertsias
Publikováno v:
Arthritis Research & Therapy, Vol 22, Iss 1, Pp 1-8 (2020)
Arthritis Research & Therapy
Arthritis Research & Therapy
Background European data indicate that systemic sclerosis (SSc)-related death rates are increasing, thus raising concerns about SSc’s optimal management. Herein, we describe current treatment modalities and drug survival in a real-life SSc cohort.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56c1ab19ab263f1cc9ff8e235ca7300f
http://link.springer.com/article/10.1186/s13075-020-2140-3
http://link.springer.com/article/10.1186/s13075-020-2140-3
Autor:
Constantina Bounia, Zinovia Kefalopoulou, Dimitra Veltsista, Elisabeth Chroni, Stamatis-Nick C. Liossis
Publikováno v:
Clinical and Experimental Rheumatology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::126e5046385d8359ea4f2734af737fad
https://doi.org/10.55563/clinexprheumatol/ey75u3
https://doi.org/10.55563/clinexprheumatol/ey75u3
Autor:
Andreas V. Goules, V. Pezoulas, Ilir I. Cinoku, Stamatis-Nick C. Liossis, Dimitrios I. Fotiadis, Haralampos M. Moutsopoulos, Athanasios G. Tzioufas, Fotini N. Skopouli, Chaido Katsimpari, Kleopatra Bitzogli, L. Chatzis, Panayiotis G. Vlachoyiannopoulos, Spyridon Katechis, Ourania D Argyropoulou, Gkikas Katsifis, Ioanna E Stergiou, Athanasios Georgountzos, Souzana Gazi, Maria Mavrommati, Paraskevi V. Voulgari, Charalampos I. Sfontouris, Athanasios-Dimitrios Bakasis, Aliki I. Venetsanopoulou, Charalampos Papagoras
Publikováno v:
Journal of Autoimmunity
Objectives To investigate humoral responses and safety of mRNA SARS-CoV-2 vaccines in systemic autoimmune and autoinflammatory rheumatic disease (SAARD) patients subjected or not to treatment modifications during vaccination. Methods A nationwide, mu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a169619ccb28e25813d604948ae5f1a
https://pubmed.ncbi.nlm.nih.gov/34757289
https://pubmed.ncbi.nlm.nih.gov/34757289
Autor:
Kleopatra Deftereou, Stylianos Panopoulos, Nafsika Gerolymatou, Antonia Elezoglou, Paraskevi V. Voulgari, Stamatis-Nick C. Liossis, Petros P. Sfikakis, Charalampos Papagoras, Vasiliki-Kalliopi Bournia, Konstantinos Melissaropoulos, Maria Pappa, Maria G Tektonidou, Evrydiki Kravvariti, Gerasimos Evangelatos, Theodoros Dimitroulas, Theodora Simopoulou, Kalliopi Fragiadaki, Georgia Mparouta, Panagiotis Georgiou, Nikoleta Zioga, Nikolaos Kougkas, Dimitrios Vassilopoulos, Evangelia Zampeli, George E Fragoulis, Evangelia Kataxaki, Dimitrios P. Bogdanos, Eleni Kalavri, Alexandros Panagiotopoulos, Anastasios Karamanakos, Aikaterini Arida, Christos Koutsianas
Publikováno v:
Annals of the rheumatic diseases. 81(7)
ObjectiveΤo report outcomes of breakthrough COVID-19 in comparison with COVID-19 in unvaccinated patients with systemic rheumatic diseases (SRDs).MethodsPatients with SRD with COVID-19 (vaccinated and unvaccinated) were included by their rheumatolog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e518cb2afeca5f383c0a503384aa954f
https://pubmed.ncbi.nlm.nih.gov/34758975
https://pubmed.ncbi.nlm.nih.gov/34758975
Autor:
Dimitrios Daoussis, Stamatis-Nick C. Liossis, Haralabos P. Kalofonos, Aikaterini Solomou, Spyridoula Theodoraki, Pantelis Kraniotis, Alexandra Filippopoulou, Thomas Makatsoris, Ioannis Kehagias, Dionysios J. Papachristou, Angelos Koutras, Rafaella Argiriadi
Publikováno v:
Rheumatology. 59:1041-1050
Objective To assess: (i) the prevalence, and clinical and imaging characteristics of immune checkpoint inhibitor (ICI)-induced musculoskeletal immune-related adverse events (ir-AEs) in a prospective manner and (ii) whether serum levels of cytokines a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2264ea59187cea845918de7802881fb8
https://doi.org/10.1093/rheumatology/kez361
https://doi.org/10.1093/rheumatology/kez361